Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2024 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2024 Earnings Call Transcript February 27, 2025Scholar Rock Holding Corporation misses on earnings expectations.
Scholar Rock Holding Corp (SRRK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 9,250,005 | $399,785,216 | 17.66% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 5,612,896 | $242,589,365 | -18% | 33.29% |
| 3. | Redmile Group Jeremy Green | 4,549,881 | $196,645,857 | -14% | 13.7% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,945,408 | $127,300,534 | +1284% | 0.15% |
| 5. | Polar Capital Brian Ashford-Russell And Tim Woolley | 2,708,371 | $117,055,795 | -8% | 0.65% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.85 | 2,189,781 | Large Shareholder, Director | 6,788,609 | 2023-10-16 | Filing | |
| $6.85 | 2,189,781 | Large Shareholder | 6,788,609 | 2023-10-16 | Filing | |
| $8.55 | 10,150 | 11,259,438 | 2023-10-12 | Filing | ||
| $6.85 | 2,189,781 | 11,249,288 | 2023-10-12 | Filing | ||
| $6.43 | 31,557 | Large Shareholder | 9,059,507 | 2023-04-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.49 | 84 | Officer | 71,750 | 2025-04-25 | Filing | |
| $32.81 | 4,916 | Officer | 71,834 | 2025-04-25 | Filing | |
| $32.89 | 5,000 | 71,750 | 2025-03-24 | Filing | ||
| $33.70 | 1,500 | 76,750 | 2025-03-24 | Filing | ||
| $33.12 | 13,564 | 82,609 | 2025-03-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 216,223 | $6,951,574 | 0% | |
| 2. | 120,752 | $3,882,165 | 0% | |
| 3. | 57,185 | $1,838,498 | 0.05% | |
| 4. | 27,366 | $879,817 | 0.18% | |
| 5. | 18,181 | $584,519 | 0.01% |
News See All
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Why These 24 Stocks Are Skyrocketing
One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to Scholar Rock's Third Quarter 2024 Financial Results and Business Update Call. All participants will be in listen-only mode.
10 Worst Falling Stocks To Buy Now
To the new investor, the stock market can appear to be an unpredictable graph that has no inherent logic to its ups and downs.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q2 2024 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q2 2024 Earnings Call Transcript August 8, 2024Scholar Rock Holding Corporation beats earnings expectations.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and...
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript
Rushmie Nofsinger: Good morning. I'm Rushmie Nofsinger, Vice President of Corporate Affairs and Investor Relations at Scholar Rock.
Billionaire Hedge Funds
